FMS Q1 2026 Earnings EPS Misses Estimates as Core Operations Face Headwinds SUPV Q1 2026 Earnings Massive EPS Beat as Company Swings to Profitability Reviva Pharmaceuticals RVPH Q1 2026 Earnings EPS Beats Estimates as Cost Discipline Drives SmallerThanExpected Loss BlackLine Q1 2026 Earnings EPS Surges 21 Above Estimates Stock Edges Lower Trupanion Q1 2026 Earnings EPS Surges Past Estimates with 505 Beat AGAE Q1 2025 Earnings Negative EPS of 011 Amid Silent Guidance and Market Decline